Tuberc Respir Dis.  2011 May;70(5):371-383.

Pneumonia in Immunocompromised Patients

• Yoon HK

Abstract

The number of immunocompromised patients has increased over the past decades due to HIV infection, solid and stem cell transplantation, intensified chemotherapy and treatment of autoimmune disease. Pneumonia is a major cause of both morbidity and mortality in immunocompromised patients. Clinical management of pneumonia is difficult, since differential diagnosis in this setting is broad and includes both infectious and noninfectious processes. Because the development of pneumonia in immunocompromised patients is frequently life threatening, early therapeutic and diagnostic intervention is essential to obtain better outcomes.

Keyword

Pneumonia; Immunocompromised Patient; Disease Management

MeSH Terms

Autoimmune Diseases
Diagnosis, Differential
Disease Management
HIV Infections
Immunocompromised Host
Pneumonia
Stem Cell Transplantation

Reference

1. Safadi AR, Soubani AO. Diagnostic approach of pulmonary disease in the HIV negative immunocompromised host. Eur J Intern Med. 2009. 20:268–279.

2. Cunha BA. Pneumonias in the compromised host. Infect Dis Clin North Am. 2001. 15:591–612.

3. Gasink LB, Blumberg EA. Bacterial and mycobacterial pneumonia in transplant recipients. Clin Chest Med. 2005. 26:647–659.

4. Baughman RP. The lung in the immunocompromised patient. Infectious complications Part 1. Respiration. 1999. 66:95–109.

5. Chakinala MM, Trulock EP. Pneumonia in the solid organ transplant patient. Clin Chest Med. 2005. 26:113–121.

6. Jain P, Sandur S, Meli Y, Arroliga AC, Stoller JK, Mehta AC. Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates. Chest. 2004. 125:712–722.

7. Hayden RT. Diagnostic microbiology of the immunocompromised host. 2009. Washington, D.C: ASM Press.

8. Corti M, Palmero D, Eiguchi K. Respiratory infections in immunocompromised patients. Curr Opin Pulm Med. 2009. 15:209–217.